Bio's of our Workshop-leaders

• Hugo Robays
  PhD, graduated as a hospital-pharmacist from the University of Gent (RUG) in 1975. He is Head of the Pharmacy and Logistic Care Dept. UZ Gent since 1996. He is also lecturer at the Faculty of Pharmacy at the University of Gent. He is member of a large number of national and international professional associations. He is Chairman of the Pharmaeconomic Committee (PEC) of the BESPE and was Co-Chairman of the 3th European Conference ISPOR (Int. Soc. Pharmacoeconomics and Outcome Research) which took place in Antwerp 2000.
• Lieven Annemans
  Lieven Annemans is a Full Professor of Health Economics at Ghent University and Brussels University. He is Past-President of ISPOR, the International Society of PharmacoEconomics and Outcomes Research and Chairman of the Flemish Health Council, an advisory board to the Minister of Public Health. He has experience in health economic evaluations of pharmaceuticals, medical devices and diagnostics, in > 20 countries, in various therapeutic areas, including alcoholism, Alzheimer’s disease, , arthritis, asthma, antibiotherapy, atrial fibrillation, pipolar disorder, BPH, burns, breast cancer, colorectal cancer, COPD, coronary heart disease, deep vein thrombosis, diabetes, fungal infections, gatric ulcers, heart failure, leukaemia, lung cancer, neutropenia oesophagitis, osteoporosis, ovarian cancer, pulmonary embolism, ulcerative colitis, vaccination,schizophrenia, sepsis, stroke, and transplantation. His educational record includes a Master’s degree in Physical Education, a Master’s degree in Management from Brussels University, a Degree in Commercial Engineering from the Solvay School of Business Economics, a degree in Health Economics from the University of Antwerp, and a PhD in Economics from Brussels University. His main interests are epidemiological models, early new technology assessment, retrospective/ prospective economic evaluations, and willingness to pay assessments.
  
• Karen Moeremans 
  HEOR Scientific Project Coordinator
  Karen graduated as an MD in 1993. She started at HEDM (now IMS Health Consulting) early 1998 as health scientist. Before joining HEDM she was active as CRA and as medical adviser for Novo Nordisk Pharma. She has gained several years of experience in the local follow-up and management of multicenter international Phase IIIa trials in diabetes and gynaecology and in providing medical information and support both to customers and within the company. Within IMS Health Consulting, she has gained experience in health economic evaluations in a variety of disease areas such as oncology, hematological oncology, gynaecology, dermatology, infectious diseases and psychiatric diseases. She has experience with a range of economic evaluation methods such as cost-effectiveness evaluations, health economic modelling, cost of illness studies, budget impact analysis, activity based costing analysis…. She is currently active as scientific project coordinator and supervisor within IMS Health Consulting. This involves management, conduct or review of HEOR projects, both at the national and international level. 

• Frank Nobels
  MD, PhD
  Training in internal medicine and endocrinology at the universities of Antwerp, Lille (France) and Rotterdam (The Netherlands).
  PhD thesis about neuroendocrine tumour markers at the Erasmus University of Rotterdam in 1999.
  Internist-endocrinologist at the department of endocrinology and metabolic diseases in the O.L.Vrouw Hospital Aalst since 1992, head of the department since 1999
  Redactor-in-chief of Diabetes Info, the magazine of the Vlaamse Diabetes Vereniging (VDV) 1995-98.
  President of the VDV 1999-2002
  President of the professional section of the VDV 2003-2006
  Coordinator of Diabetes Project Flanders to improve first-line diabetes care
  Coordinator of the initiative for quality assurance and epidemiology (IKED) for Belgian diabetes centers.
  Member of the board of the Belgian Endocrine Society
  Co-organizer of the yearly Erasmus Course in Endocrinology (EMCO) for Flemish and Dutch endocrinologists.
  Author of several scientific papers and book chapters on diabetes and neuroendocrine tumours.
•  Karen Moeremans 
  HEOR Scientific Project Coordinator. Karen graduated as an MD in 1993. She started at HEDM (now IMS Health Consulting) early 1998 as health scientist. Before joining HEDM she was active as CRA and as medical adviser for Novo Nordisk Pharma. She has gained several years of experience in the local follow-up and management of multicenter international Phase IIIa trials in diabetes and gynaecology and in providing medical information and support both to customers and within the company. Within IMS Health Consulting, she has gained experience in health economic evaluations in a variety of disease areas such as oncology, hematological oncology, gynaecology, dermatology, infectious diseases and psychiatric diseases. She has experience with a range of economic evaluation methods such as cost-effectiveness evaluations, health economic modelling, cost of illness studies, budget impact analysis, activity based costing analysis…. She is currently active as scientific project coordinator and supervisor within IMS Health Consulting. This involves management, conduct or review of HEOR projects, both at the national and international level.